Literature DB >> 15761964

Prognostic values of tumor endothelial markers in patients with colorectal cancer.

K A Rmali1, M C A Puntis, W G Jiang.   

Abstract

AIM: Tumor endothelial markers (TEMs) are a newly discovered family of endothelial markers associated with tumor specific angiogenesis. This study sought to examine the levels of expression (qualitatively and quantitatively) for TEMs in human colon cancer.
METHODS: Human colorectal cancer tissues (n = 48) and normal background tissues (n = 31) were obtained after surgery. RNA was extracted from frozen sections for gene amplification. The expression of TEMs (TEM-1 to TEM-8) was assessed using RT-PCR and their transcript levels were determined using real-time-quantitative PCR (Q-RT-PCR).
RESULTS: TEM-1 (P = 0.01), TEM-7 (P = 0.04), TEM-7R (P = 0.03), TEM-8 (P = 0.001) significantly raised in colon cancer tissues compared with the levels detected in normal background tissues. The expressions of TEM-2 and TEM-6 were found to be not significantly different between tumor tissues and normal tissues (P > 0.05). Patients who had cancer penetrating into and through the muscularis propria of the bowel wall and developed nodal involvement (Dukes C) exhibited significantly higher levels of TEM -8 compared to patients who were node negative (P < 0.05). TEM-7 and TEM-7R showed high level of transcripts in Dukes C, but they were not statistically significant.
CONCLUSION: The level of the expression of TEM-1, TEM-7, TEM-7R and TEM-8 (but not TEM-2 and TEM-6) were associated with both nodal involvement and disease progression, and may therefore, have a prognostic value in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761964      PMCID: PMC4250673          DOI: 10.3748/wjg.v11.i9.1283

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  Genes expressed in human tumor endothelium.

Authors:  B St Croix; C Rago; V Velculescu; G Traverso; K E Romans; E Montgomery; A Lal; G J Riggins; C Lengauer; B Vogelstein; K W Kinzler
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

Review 2.  Role of integrins in cell invasion and migration.

Authors:  John D Hood; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

3.  Antiangiogenesis drug promising for metastatic colorectal cancer.

Authors:  Michael McCarthy
Journal:  Lancet       Date:  2003-06-07       Impact factor: 79.321

Review 4.  The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms.

Authors:  A Colombatti; P Bonaldo
Journal:  Blood       Date:  1991-06-01       Impact factor: 22.113

Review 5.  Ligand recognition by the I domain-containing integrins.

Authors:  S K Dickeson; S A Santoro
Journal:  Cell Mol Life Sci       Date:  1998-06       Impact factor: 9.261

Review 6.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

7.  Cell surface tumor endothelial markers are conserved in mice and humans.

Authors:  E B Carson-Walter; D N Watkins; A Nanda; B Vogelstein; K W Kinzler; B St Croix
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

8.  Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18).

Authors:  J O Lee; P Rieu; M A Arnaout; R Liddington
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

9.  Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer.

Authors:  Gaynor Davies; Giles H Cunnick; Robert E Mansel; Malcolm D Mason; Wen G Jiang
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

10.  Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers.

Authors:  Wen G Jiang; Gareth Watkins; Jane Lane; Giles H Cunnick; Anthony Douglas-Jones; Kefah Mokbel; Robert E Mansel
Journal:  Clin Cancer Res       Date:  2003-12-15       Impact factor: 12.531

View more
  26 in total

1.  Anti-tumor angiogenesis effect of genetic fusion vaccine encoding murine beta-defensin 2 and tumor endothelial marker-8 in a CT-26 murine colorectal carcinoma model.

Authors:  Ping Liu; Ganfeng Xie; Peiliang Geng; Chenhong Zheng; Jianjun Li; Feng Pan; Zhihua Ruan; Houjie Liang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.

Authors:  Aizhi Zhao; Selene Nunez-Cruz; Chunsheng Li; George Coukos; Don L Siegel; Nathalie Scholler
Journal:  J Immunol Methods       Date:  2010-09-15       Impact factor: 2.303

3.  Genomics of Colorectal Cancer in African Americans.

Authors:  Hassan Brim; Hassan Ashktorab
Journal:  Next Gener Seq Appl       Date:  2016-09-21

4.  Development of 124I immuno-PET targeting tumor vascular TEM1/endosialin.

Authors:  Ann-Marie Chacko; Chunsheng Li; Madhura Nayak; John L Mikitsh; Jia Hu; Catherine Hou; Luigi Grasso; Nicholas C Nicolaides; Vladimir R Muzykantov; Chaitanya R Divgi; George Coukos
Journal:  J Nucl Med       Date:  2014-02-13       Impact factor: 10.057

5.  Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration.

Authors:  Brian Tomkowicz; Katherine Rybinski; Brian Foley; Wolfgang Ebel; Brad Kline; Eric Routhier; Philip Sass; Nicholas C Nicolaides; Luigi Grasso; Yuhong Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-06       Impact factor: 11.205

6.  Prognostic value of tumour endothelial markers in patients with endometrial cancer.

Authors:  Nick A Bersinger; Brigitte Schneider; Stephan A Vorburger; Silke Johann; Daniel Candinas; Michael D Mueller
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

Review 7.  Molecular mediators of angiogenesis.

Authors:  Areck A Ucuzian; Andrew A Gassman; Andrea T East; Howard P Greisler
Journal:  J Burn Care Res       Date:  2010 Jan-Feb       Impact factor: 1.845

8.  The simultaneous expression of peroxisome proliferator-activated receptor delta and cyclooxygenase-2 may enhance angiogenesis and tumor venous invasion in tissues of colorectal cancers.

Authors:  Masahiro Yoshinaga; Yosuke Kitamura; Tomohito Chaen; Shinsaku Yamashita; Satoru Tsuruta; Teruaki Hisano; Yoichi Ikeda; Hironori Sakai; Kazuhiko Nakamura; Ryoichi Takayanagi; Yoichi Muto
Journal:  Dig Dis Sci       Date:  2008-08-23       Impact factor: 3.199

9.  Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis.

Authors:  Lin Ye; Ping-Hui Sun; Muhammad Faraz Arshad Malik; Malcolm D Mason; Wen G Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-26       Impact factor: 4.553

10.  Genomic aberrations in an African American colorectal cancer cohort reveals a MSI-specific profile and chromosome X amplification in male patients.

Authors:  Hassan Brim; Edward Lee; Mones S Abu-Asab; Mohamed Chaouchi; Hadi Razjouyan; Hassanzadeh Namin; Ajay Goel; Alejandro A Schäffer; Hassan Ashktorab
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.